Condition (MeSH)
Orbital Pseudotumor
ClinicalTrials.gov lists 4 trials for Orbital Pseudotumor or a narrower condition beneath it. Fondation Ophtalmologique Adolphe de Rothschild has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Orbital Pseudotumor itself; the rest are tagged with a narrower condition beneath it.
When did Orbital Pseudotumor trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 3
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2015 | 1 |
| 2012 | 2 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Orbital Pseudotumor trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 3 | 1 |
| Observational | 2 |
How many Orbital Pseudotumor trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Orbital Pseudotumor trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Fondation Ophtalmologique Adolphe de Rothschild | 1 |
Which serious adverse events do Orbital Pseudotumor trials report? (6)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Amaurosis fugax | 1 | 1 |
| Klebsiella urinary tract infection | 1 | 1 |
| Legionella pneumophila pneumonia | 1 | 1 |
| Surgery for pseudotumor | 1 | 1 |
| cold agglutininmediated | 1 | 1 |
Showing 5 of 6 adverse events.
Which publications cover Orbital Pseudotumor? (11)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Intralesional corticosteroid injections as treatment for non-infectious orbital inflammation. | Orbit (Amsterdam, Netherlands) | 2018 | Yes |
| Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial. | JAMA ophthalmology | 2014 | Yes |
| Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study. | Ophthalmic plastic and reconstructive surgery | 2013 | Yes |
| Treatment of severe idiopathic orbital inflammation with intravenous methylprednisolone. | The British journal of ophthalmology | 2011 | Yes |
| Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. | The British journal of ophthalmology | 2007 | Yes |
Showing 5 of 11 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.